Yuanheng Biotechnology Co., Ltd.
Yuan Heng Biotechnology Co., Ltd. is located in Chahar Industrial Park, Wulanchabu City, Inner Mongolia, China. It passed the GMP inspection of the Ministry of Agriculture in December 2014 and built five modern production workshops and 16 GMP production lines. It can produce 14 series of products such as injection, oral liquid, tincture, perfusate, tablet, granule, premix, disinfectant, etc.
The company has obtained 68 veterinary drug patents. In the field of R&D and application, it is one of the largest and most comprehensive veterinary drug manufacturers in Mainland China.
The actual investment of Yuan Heng Biology is 120 million yuan, the registered capital is 50 million yuan, and the designed production capacity is 650 million yuan/year. It has planned to invest 300 million yuan in 2020 to build a project for deep processing of traditional Chinese medicine and biological vaccine.
Strategy: Hunan Mawangdui Bio-Pharmaceutical Joint Research and Development Base
Collaboration: Cooperate with Huada (BGI) to build the most influential genetics research center in China. Establish long-term and in-depth cooperative relations with the United States, Japan and other research and development institutions.
BGI Group, is a genome sequencing company, headquartered in Shenzhen, Guangdong, China. It was formed in 1999 to participate in the Human Genome Project, and is the world’s largest genetics research center. It is considered to be world’s leader in gene-sequencing services, also sequencing genomes of other animals, plants and microorganisms.
Vision: It plans to list the company’s shares in 2025.
Mission: Promote the Healthy and Green Development of the Aquaculture Industry and Help the National Food Safety Project
Expand Health Industry, Serve the Public and Benefit the World
Company: Yuanheng Biotechnology Co., Ltd.
Address: Chahar Industrial Park, Ulanchabu City, Inner Mongolia Province, China.
ZIP code: 012000
Telephone number: + 86 131 3007 0471